Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c389
Identifier NCT05384080
Trial Title A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease (IBD)|Crohn's Disease|Ulcerative Colitis
Interventions -
Participant Information
Sponsor Takeda
City Wroclaw
Country/Region Poland
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2022-08-08
Primary Completion Date 2025-08-01
Completion Date 2025-08-01